A Study of Intradermal Administration of ZOSTAVAX™ (V211-051 AM2)
Clinical trial NCT01385566 · COMPLETED
Trial details
- NCT number
- NCT01385566
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2013-05-01
- Enrollment
- 223
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.